Comparison of long-term outcomes of endoscopic submucosal dissection and surgery for early esophageal cancer

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200064868

Enrollment

Unknown

Registered

2022-10-20

Start date

2022-10-20

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early esophageal cancer

Interventions

Case series:None

Eligibility

Sex/Gender

All

Age

27 Years to 86 Years

Inclusion criteria

Inclusion criteria: 1. During the period from 2010 to 2020, patients who are within the absolute and expanded indications of ESD treatment, and whose biopsy pathology showed early esophageal squamous cell carcinoma and received ESD or surgery; 2. Esophageal cancer is the first primary tumor, and there is only one primary tumor; 3. The survival status and survival time are clear;

Exclusion criteria

Exclusion criteria: 1. Esophageal cancer with confirmed lymph node metastasis or distant metastasis; 2. Patients with a history of malignant tumor treatment within five years; 3. Patients with other serious underlying medical conditions, such as heart disease, respiratory failure, and severe kidney or liver insufficiency.

Design outcomes

Primary

Measure	Time frame
survival rate;	—

Countries

China

Contacts

Public ContactZhou Xiaoying

Jiangsu Province Hospital

zhouxiaoying0926@sina.cn+86 15850668395

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026